Sponsor or institution

Clinical trials and research at Kura Oncology, Inc.

• 5Clinical trials
• 17Countries

Newest trials

All recruiting trials (5)

• Ziftomenib with standard chemotherapy or venetoclax+azacitidine for newly diagnosed NPM1‑mutated or KMT2A‑rearranged AML

  This trial will test whether adding ziftomenib to standard chemotherapy (7+3) or to venetoclax plus azacitidine helps adults with newly diagnosed NPM1‑mutated or KMT2A‑rearranged AML achieve better remissions and longer survival.

  Recruiting at 134 sites Phase 3 Kura Oncology, Inc. · Gilbert, Arizona and 135 other locations · NCT07007312

• Combining ziftomenib and imatinib for advanced gastrointestinal stromal tumors

  This study is testing whether combining two medications, ziftomenib and imatinib, can help adults with advanced gastrointestinal stromal tumors who haven't responded well to imatinib alone.

  Recruiting at 32 sites Phase 1 Kura Oncology, Inc. · Birmingham, Alabama and 31 other locations · NCT06655246

• Testing KO-2806 for advanced solid tumors

  This study is testing a new treatment called KO-2806 for adults with advanced solid tumors that have certain genetic changes to see if it can help them feel better.

  Recruiting at 38 sites Phase 1 Kura Oncology, Inc. · Phoenix, Arizona and 37 other locations · NCT06026410

• Examining the safety of ziftomenib combinations for patients with relapsed acute myeloid leukemia

  This study is testing if combining ziftomenib with standard treatments can safely help people with relapsed acute myeloid leukemia feel better and improve their chances of recovery.

  Recruiting at 43 sites Phase 1 Kura Oncology, Inc. · Gilbert, Arizona and 44 other locations · NCT06001788

• Investigating Ziftomenib with Other Treatments for Acute Myeloid Leukemia

  This study is testing if a new drug called ziftomenib, when combined with other treatments, can help people with acute myeloid leukemia who have certain genetic mutations feel better and stay safe during treatment.

  Recruiting at 44 sites Phase 1 Kura Oncology, Inc. · Phoenix, Arizona and 43 other locations · NCT05735184

Quick answers

How many clinical trials run by Kura Oncology, Inc. are recruiting right now?

5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 17 countries. The most sites are in United States (5 trials), Italy (3 trials), Spain (3 trials), France (2 trials), Germany (2 trials). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1: 4, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →